Seizure Therapy With Intravenous Levetiracetam and Lorazepam.

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II/III

Latest Information Update: 30 Oct 2014

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Levetiracetam (Primary) ; Lorazepam
Indications Seizures
Focus Therapeutic Use
Acronyms STILL

Most Recent Events

18 Apr 2012 Actual end date changed from Dec 2010 to May 2010 as reported by ClinicalTrials.gov.
19 Jul 2011 Status changed from recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
27 May 2008 Patient numbers amended from 350 to 100 as reported by ClinicalTrials.gov.

Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

IP authentication when working within your organization’s network.
Login with username/password or try access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days.
Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

Contact your organization’s admin about adding this content to your AdisInsight subscription
Buy a PDF version of the profile.
Request a free trial

Welcome to AdisInsight